B Li, X Jin, H Meng, B Hu, T Zhang, J Yu, S Chen… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Paclitaxel is a first-line microtubule-stabilizing drug in treating prostate cancer. However,
most patients develop resistance and experience relapse. Morin (3, 5, 7, 20, 40 …